German manufacturers face up to “everyday” concept of medtech benefit assessment
This article was originally published in Clinica
Executive Summary
A €36m ($45m) fund to support applications to fast-track reimbursement of promising medtech products has been proposed in Germany. CDU MP Dietrich Monstadt and joint federal committee ( G-BA) director Rainer Hess outlined the plan to create the fund at an industry-hosted meeting last week in Berlin.